MedPath

Evaluating Biobanking Educational Tools

Not Applicable
Completed
Conditions
Neoplasm
Interventions
Other: TBCCN-developed educational materials
Other: NCI-developed educational materials
Registration Number
NCT01672944
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Brief Summary

The purpose of this study is to evaluate English and Spanish language educational materials that inform the community about a type of cancer research that involves the collection, storage, and processing of biospecimens. Part A of this study involved creating surveys about biospecimen donation and research. Now, a randomized controlled trial (RCT) will begin to evaluate education materials about biospecimen donation and research.

Phase II consists of two independent randomized controlled trials. Each trial is being conducted independently to test English and Spanish language materials (75 subjects each).

Detailed Description

The project addresses gaps in information by developing and validating English and Spanish language instruments to measure knowledge of and attitudes towards biospecimen donation and banking, as well as intention to donate biospecimens to a biobank (Part A). Once developed, the instruments will be used to evaluate biobanking educational priming tools by conducting two independent RCTs. Wherein English educational materials will be tested with 75 participants recruited from an urban clinic, and Spanish educational materials will be tested with 75 participant recruited form a rural community health center network. For each RCT following baseline assessment, participants will be randomized to either: 1) educational priming tools (DVD and booklet) developed by the Tampa Bay Community Cancer Network (TBCCN); or 2) an NCI-developed brochure entitled "Providing Your Tissue for Research: What You Need to Know." Seven to 28 days later participants will be given a telephone follow up interview.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
339
Inclusion Criteria
  • scheduled for an appointment at Lifetime Cancer Screening (LCS)
  • able to read and speak English
  • able to provide informed consent

Spanish Language RCT Inclusion Criteria:

  • receiving care at a participating clinic from the Suncoast Community Health Centers network
  • able to read and speak Spanish
  • able to provide informed consent
Exclusion Criteria
  • previously diagnosed with cancer
  • previously participated in a biobank
  • participated in another TBCCN-related study entitled "community perceptions on biobanking"

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TBCCN-developed educational materialsTBCCN-developed educational materialsBiobanking educational DVD and booklet kit developed by the Tampa Bay Community Network (TBCCN) Center. English kit is entitled "Biobanking Hope for a Cancer Cure", and Spanish kit is entitled "Biobanco: Una esperanza de cura para el cancer."
Control GroupNCI-developed educational materialsBiobanking educational Brochure developed by the National Cancer Institute. English brochure is entitled "Providing your Tissue for Research: What you need to Know", Spanish brochure is entitled "Lo que usted debe saber antes de dar sus tejidos para investigación médica."
Primary Outcome Measures
NameTimeMethod
BANKS-Knowledge ScaleAverage of 28 days

Administered at baseline and between 7 and 28 days after enrollment. Description: A validated 16-item questionnaire measuring knowledge about biobanking.

BANKS-Attitudes ScaleAverage of 28 days

Administered at baseline and between 7 and 28 days after enrollment. Description: A validated 15-item questionnaire measuring attitudes toward biobanking.

BANKS-Self-Efficacy ScaleAverage of 28 days

Administered at baseline and between 7 and 28 days after enrollment. Description: A validated 12-item questionnaire measuring self-efficacy in regards to donating a biospecimen to a biobank.

BANKS-IntentionsAverage of 28 days

Administered at baseline. Description: A single item measuring intentions to donate a biospecimen to a biobank.

Decisional Self-EfficacyAverage of 28 days

Administered at follow-up (between 7 and 28 days after enrollment). Description: A validated 11-item questionnaire measuring participant's confidence in making a decision about donating a biospecimen (O'Connor M.A. Decision Self-efficacy Scale. 1995; www.ohri.ca/decisionaid).

Secondary Outcome Measures
NameTimeMethod
BANKS-Trust ScaleAverage of 28 days

Administered at baseline and between 7 and 28 days after enrollment. Description: A validated 10-item questionnaire measuring trust related to organizations, facilities, and people that may be involved in research.

Trial Locations

Locations (1)

H. Lee Moffitt Cancer Center and Research Institute

🇺🇸

Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath